ASH24: Jennifer Brown, MD | Dana-Farber Cancer Institute

Поделиться
HTML-код
  • Опубликовано: 2 янв 2025
  • Dana-Farber Cancer Institute's Jennifer Brown, MD, PhD, shared results at #ASH24 from the Phase 3 AMPLIFY trial: novel oral regimens show promise for CLL with durable, deep responses.
    Read more: bit.ly/3OOgPNj
    Video published 12/18/2024

Комментарии •